• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IPULSE MEDICAL LIVIA TENS UNIT; STIMULATOR, NERVE, TRANSCUTANEOUS, OVER-THE-COUNTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IPULSE MEDICAL LIVIA TENS UNIT; STIMULATOR, NERVE, TRANSCUTANEOUS, OVER-THE-COUNTER Back to Search Results
Medical Device Problem Code Shipping Damage or Problem (1570)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Type of Reportable Event Malfunction
Event or Problem Description
Livia is a period pain reduction unit.This tens unit does work but the company is scamming thousands of women.The site contains no address or phone number.They take your money and send no product.There is a subscription service, they are taking out the (b)(6) a month consistently but not providing any of the tools needed to keep using the product.I have emailed dozens of times and they simply will not respond.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIVIA TENS UNIT
Common Device Name
STIMULATOR, NERVE, TRANSCUTANEOUS, OVER-THE-COUNTER
Manufacturer (Section D)
IPULSE MEDICAL
MDR Report Key10250481
Report NumberMW5095446
Device Sequence Number3475719
Product Code NUH
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 07/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date07/08/2020
Patient Sequence Number1
Patient Age30 YR
Patient Weight93
-
-